(Q40173304)

18 September 2017

title

Novel 111In-labelled bombesin analogues for molecular imaging of prostate tumours (English)

1 reference

18 September 2017

de Visser M

1

1 reference

18 September 2017

Bernard HF

2

1 reference

18 September 2017

Erion JL

3

1 reference

18 September 2017

Schmidt MA

4

1 reference

18 September 2017

Srinivasan A

5

1 reference

18 September 2017

Waser B

6

1 reference

18 September 2017

Reubi JC

7

1 reference

18 September 2017

Krenning EP

8

1 reference

18 September 2017

de Jong M

9

1 reference

18 September 2017

publication date

8 February 2007

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

18 September 2017

published in

1 reference

18 September 2017

volume

34

1 reference

18 September 2017

issue

8

1 reference

18 September 2017

page(s)

1228-1238

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-006-0356-3

18 September 2017

exact match

0 references

cites work

Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00259-006-0356-3

Mammalian bombesin receptors

21 January 2018

1 reference

12 December 2020

Evaluation of radiolabelled bombesin analogues for receptor-targeted scintigraphy and radiotherapy

1 reference

12 December 2020

Peptide receptor imaging and therapy

1 reference

12 December 2020

Radiolabelled peptides for tumour therapy: current status and future directions. Plenary lecture at the EANM 2002.

1 reference

12 December 2020

Inhibitory effect of bombesin receptor antagonist RC-3095 on the growth of human pancreatic cancer cells in vivo and in vitro

1 reference

12 December 2020

Bombesin specifically induces intracellular calcium mobilization via gastrin-releasing peptide receptors in human prostate cancer cells

1 reference

12 December 2020

DOTATOC: a powerful new tool for receptor-mediated radionuclide therapy

1 reference

12 December 2020

Radiochemical investigations of gastrin-releasing peptide receptor-specific [(99m)Tc(X)(CO)3-Dpr-Ser-Ser-Ser-Gln-Trp-Ala-Val-Gly-His-Leu-Met-(NH2)] in PC-3, tumor-bearing, rodent models: syntheses, radiolabeling, and in vitro/in vivo studies where D

1 reference

12 December 2020

Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

1 reference

12 December 2020

Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings

1 reference

12 December 2020

The clinical value of [90Y-DOTA]-D-Phe1-Tyr3-octreotide (90Y-DOTATOC) in the treatment of neuroendocrine tumours: a clinical phase II study

1 reference

12 December 2020

In vitro and in vivo evaluation of a 99mTc(I)-labeled bombesin analogue for imaging of gastrin releasing peptide receptor-positive tumors

1 reference

12 December 2020

Use of the rat pancreatic CA20948 cell line for the comparison of radiolabelled peptides for receptor-targeted scintigraphy and radionuclide therapy

1 reference

12 December 2020

Novel series of 111In-labeled bombesin analogs as potential radiopharmaceuticals for specific targeting of gastrin-releasing peptide receptors expressed on human prostate cancer cells

1 reference

12 December 2020

Co-expressed peptide receptors in breast cancer as a molecular basis for in vivo multireceptor tumour targeting

1 reference

12 December 2020

In vivo inhibition of PC-3 human androgen-independent prostate cancer by a targeted cytotoxic bombesin analogue, AN-215

1 reference

12 December 2020

Species differences of bombesin analog interactions with GRP-R define the choice of animal models in the development of GRP-R-targeting drugs

1 reference

12 December 2020

Clinical correlates of bombesin-like peptide receptor subtype expression in human lung cancer cells.

1 reference

12 December 2020

Yttrium-90-labelled somatostatin-analogue for cancer treatment

1 reference

12 December 2020

Cloning and Functional Characterization of a Complementary DNA Encoding the Murine Fibroblast Bombesin/Gastrin-Releasing Peptide Receptor

1 reference

12 December 2020

[177Lu-DOTAOTyr3]octreotate: comparison with [111In-DTPAo]octreotide in patients

1 reference

12 December 2020

In vivo application of [111In-DTPA-D-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in rats

1 reference

12 December 2020

Some pharmacological actions of alytesin and bombesin

1 reference

12 December 2020

Characterization of high-affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC-3 and DU-145: internalization of receptor bound 125I-(Tyr4) bombesin by tumor cells

1 reference

12 December 2020

Cancer statistics, 2006

1 reference

12 December 2020

Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study

1 reference

12 December 2020

Radiochemical investigations of 177Lu-DOTA-8-Aoc-BBN[7-14]NH2: an in vitro/in vivo assessment of the targeting ability of this new radiopharmaceutical for PC-3 human prostate cancer cells

1 reference

12 December 2020

Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA(0),Tyr3]octreotate

1 reference

12 December 2020

Internalization of radiolabelled [DTPA0]octreotide and [DOTA0,Tyr3]octreotide: peptides for somatostatin receptor-targeted scintigraphy and radionuclide therapy

1 reference

12 December 2020

Localization and characterization of neuropeptide receptors in human colon

1 reference

12 December 2020

The human gastrin-releasing peptide receptor gene structure, its tissue expression and promoter

1 reference

12 December 2020

Gastrin-releasing peptide (mammalian bombesin) gene expression in health and disease.

1 reference

12 December 2020

The Role of Somatostatin and Its Analogs in the Diagnosis and Treatment of Tumors

1 reference

12 December 2020

Synthesis and evaluation of bombesin derivatives on the basis of pan-bombesin peptides labeled with indium-111, lutetium-177, and yttrium-90 for targeting bombesin receptor-expressing tumors

1 reference

12 December 2020

Peptide receptors as molecular targets for cancer diagnosis and therapy

1 reference

12 December 2020

Biodistribution and dosimetry of (99m)Tc-RP527, a gastrin-releasing peptide (GRP) agonist for the visualization of GRP receptor-expressing malignancies.

1 reference

12 December 2020

Tolerance of normal tissue to therapeutic irradiation

1 reference

12 December 2020

Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy.

1 reference

12 December 2020

Presence of receptors for bombesin/gastrin-releasing peptide and mRNA for three receptor subtypes in human prostate cancers

1 reference

12 December 2020

Characterization of bombesin/gastrin-releasing peptide receptors in human breast cancer and their relationship to steroid receptor expression

1 reference

12 December 2020

Location and characterization of the human GRP receptor expressed by gastrointestinal epithelial cells

1 reference

12 December 2020

Potent bombesin-like peptides for GRP-receptor targeting of tumors with 99mTc: a preclinical study

1 reference

12 December 2020

Bombesin receptor subtypes in human cancers: detection with the universal radioligand (125)I-[D-TYR(6), beta-ALA(11), PHE(13), NLE(14)] bombesin(6-14)

1 reference

12 December 2020

Pre-clinical evaluation of [(111)In-DTPA-Pro(1), Tyr(4)]bombesin, a new radioligand for bombesin-receptor scintigraphy

1 reference

12 December 2020

MicroPET imaging of a gastrin-releasing peptide receptor-positive tumor in a mouse model of human prostate cancer using a 64Cu-labeled bombesin analogue.

1 reference

12 December 2020

Cloning of a receptor for amphibian [Phe13]bombesin distinct from the receptor for gastrin-releasing peptide: identification of a fourth bombesin receptor subtype (BB4)

1 reference

12 December 2020

[111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation.

1 reference

12 December 2020

68Ga-labelled DOTA-derivatised peptide ligands

1 reference

12 December 2020

cDNA cloning, characterization, and brain region-specific expression of a neuromedin-B-preferring bombesin receptor

1 reference

12 December 2020

[99mTc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging

1 reference

12 December 2020

Gastrin-releasing peptide receptors in the human prostate: relation to neoplastic transformation.

1 reference

12 December 2020

Receptor-mediated radiotherapy with 90Y-DOTA-D-Phe1-Tyr3-octreotide

1 reference

12 December 2020

GRP receptor-targeted PET of a rat pancreas carcinoma xenograft in nude mice with a 68Ga-labeled bombesin(6-14) analog

1 reference

12 December 2020

Development of seven new human prostate tumor xenograft models and their histopathological characterization.

1 reference

12 December 2020

BRS-3: a novel bombesin receptor subtype selectively expressed in testis and lung carcinoma cells

1 reference

12 December 2020

microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts.

1 reference

12 December 2020

In situ hybridization for gastrin-releasing peptide receptor (GRP receptor) expression in prostatic carcinoma

1 reference

12 December 2020

10.1007/S00259-006-0356-3

Identifiers

DOI

1 reference

18 September 2017

1 reference